MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
VRNA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Verona Pharma (VRNA) Earnings Date & Reports

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs... Show more

A.I. Advisor
published Earnings

VRNA is expected to report earnings to fall 959.00% to 17 cents per share on November 11

Verona Pharma VRNA Stock Earnings Reports
Q3'25
Est.
$0.17
Q1'25
Beat
by $0.05
Q4'24
Beat
by $0.02
Q3'24
Est.
$-0.07
Q2'24
Missed
by $0.06
The last earnings report on April 29 showed earnings per share of -1 cents, beating the estimate of -7 cents. With 1.86M shares outstanding, the current market capitalization sits at 9.08B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
VRNA
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For VRNA
(Try 14 days for Free)
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VRNA showed earnings on April 29, 2025. You can read more about the earnings report here.
View AI-Driven Trading
A.I. Advisor
published General Information

General Information

a r&d company for the treatment of allergic rhinitis and other chronic respiratory diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
3 More London Riverside
Phone
+44 2032834200
Employees
79
Web
https://www.veronapharma.com